5 Best Dividend Stocks According to Andreas Halvorsen’s Viking Global

4. Royalty Pharma plc (NASDAQ:RPRX)

Number of Hedge Fund Holders: 20
Viking Global’s Stake Value: $411,068,000
Dividend Yield as of February 15: 1.92%

Royalty Pharma plc (NASDAQ:RPRX) is the largest buyer of pharmaceutical royalties and also funds innovation in the industry. This December, Tigress Financial appreciated the company’s significant revenue growth, cash flow, and dividend increases. The firm lifted its price target on the stock to $52, with a Buy rating on the shares.

Warren Buffett’s Berkshire Hathaway was the second-largest shareholder of Royalty Pharma plc (NASDAQ:RPRX) in Q3 2021, owning shares valued at over $475 million. Overall, 20 hedge funds tracked by Insider Monkey held stakes in the company in Q3, the same as in the previous quarter. These stakes hold a value of nearly $2 billion.

Royalty Pharma plc (NASDAQ:RPRX) started giving dividends to shareholders right after its IPO in 2020. Since then, the company has increased its dividend two times, recently growing it by 12%. Royalty Pharma plc (NASDAQ:RPRX) pays a quarterly dividend of $0.19 per share, with a dividend yield of 1.92%. Viking Global increased its stake in the company by 150% in Q4, which made up 1.19% of its 13F portfolio.